Antimicrobial Stewardship in Care Homes: Outcomes of Importance to Stakeholders

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Heterogeneity of outcomes measured in trials to improve antimicrobial stewardship (AMS) in care homes has compromised quality of evidence. A core outcome set (COS) is needed to facilitate interpretation and synthesis of evidence in this area.

AIM: To determine outcomes deemed important by relevant stakeholders for interventions aimed at improving AMS in care homes, and to produce a refined list of outcomes that could be considered for use in future research.

METHODS: Semi-structured face-to-face or telephone interviews were conducted with key stakeholders. Outcomes reported in previous randomised controlled trials (RCTs) of AMS in care homes were included in a topic guide for interviews. Content analysis was undertaken to identify potential outcomes suggested by participants, followed by further review.

FINDINGS: Twenty-seven outcomes reported in RCTs were refined into a list of 12 overarching outcomes. Interviews with participants (six researchers, 31 healthcare professionals, and four family members of care home residents) identified 40 additional outcomes that were important to them. From these 52 outcomes, the total number of antimicrobials, the appropriateness of antimicrobial prescribing and adherence to guidelines were highlighted by most participants. After reviewing all 52 outcomes, a refined list of 14 outcomes potentially feasible for use in AMS trials in care homes was generated.

CONCLUSION: A number of potential outcomes for AMS in care homes, some of which had not been reported in previous studies, were identified. The refined list of 14 outcomes will be used in a future study to agree a COS for care home AMS trials.

Original languageEnglish
JournalThe Journal of hospital infection
Early online date10 Jan 2020
DOIs
Publication statusEarly online date - 10 Jan 2020

Fingerprint

Home Care Services
Interviews
Randomized Controlled Trials
Guideline Adherence
Research Personnel
Delivery of Health Care

Bibliographical note

Copyright © 2020. Published by Elsevier Ltd.

Cite this

@article{cfd2eee170164ca99d6398a5230ed1df,
title = "Antimicrobial Stewardship in Care Homes: Outcomes of Importance to Stakeholders",
abstract = "BACKGROUND: Heterogeneity of outcomes measured in trials to improve antimicrobial stewardship (AMS) in care homes has compromised quality of evidence. A core outcome set (COS) is needed to facilitate interpretation and synthesis of evidence in this area.AIM: To determine outcomes deemed important by relevant stakeholders for interventions aimed at improving AMS in care homes, and to produce a refined list of outcomes that could be considered for use in future research.METHODS: Semi-structured face-to-face or telephone interviews were conducted with key stakeholders. Outcomes reported in previous randomised controlled trials (RCTs) of AMS in care homes were included in a topic guide for interviews. Content analysis was undertaken to identify potential outcomes suggested by participants, followed by further review.FINDINGS: Twenty-seven outcomes reported in RCTs were refined into a list of 12 overarching outcomes. Interviews with participants (six researchers, 31 healthcare professionals, and four family members of care home residents) identified 40 additional outcomes that were important to them. From these 52 outcomes, the total number of antimicrobials, the appropriateness of antimicrobial prescribing and adherence to guidelines were highlighted by most participants. After reviewing all 52 outcomes, a refined list of 14 outcomes potentially feasible for use in AMS trials in care homes was generated.CONCLUSION: A number of potential outcomes for AMS in care homes, some of which had not been reported in previous studies, were identified. The refined list of 14 outcomes will be used in a future study to agree a COS for care home AMS trials.",
author = "Nguyen, {Hoa Q} and Bradley, {Declan T} and Tunney, {Michael M} and Hughes, {Carmel M}",
note = "Copyright {\circledC} 2020. Published by Elsevier Ltd.",
year = "2020",
month = "1",
day = "10",
doi = "10.1016/j.jhin.2019.12.024",
language = "English",
journal = "The Journal of hospital infection",
issn = "0195-6701",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Antimicrobial Stewardship in Care Homes: Outcomes of Importance to Stakeholders

AU - Nguyen, Hoa Q

AU - Bradley, Declan T

AU - Tunney, Michael M

AU - Hughes, Carmel M

N1 - Copyright © 2020. Published by Elsevier Ltd.

PY - 2020/1/10

Y1 - 2020/1/10

N2 - BACKGROUND: Heterogeneity of outcomes measured in trials to improve antimicrobial stewardship (AMS) in care homes has compromised quality of evidence. A core outcome set (COS) is needed to facilitate interpretation and synthesis of evidence in this area.AIM: To determine outcomes deemed important by relevant stakeholders for interventions aimed at improving AMS in care homes, and to produce a refined list of outcomes that could be considered for use in future research.METHODS: Semi-structured face-to-face or telephone interviews were conducted with key stakeholders. Outcomes reported in previous randomised controlled trials (RCTs) of AMS in care homes were included in a topic guide for interviews. Content analysis was undertaken to identify potential outcomes suggested by participants, followed by further review.FINDINGS: Twenty-seven outcomes reported in RCTs were refined into a list of 12 overarching outcomes. Interviews with participants (six researchers, 31 healthcare professionals, and four family members of care home residents) identified 40 additional outcomes that were important to them. From these 52 outcomes, the total number of antimicrobials, the appropriateness of antimicrobial prescribing and adherence to guidelines were highlighted by most participants. After reviewing all 52 outcomes, a refined list of 14 outcomes potentially feasible for use in AMS trials in care homes was generated.CONCLUSION: A number of potential outcomes for AMS in care homes, some of which had not been reported in previous studies, were identified. The refined list of 14 outcomes will be used in a future study to agree a COS for care home AMS trials.

AB - BACKGROUND: Heterogeneity of outcomes measured in trials to improve antimicrobial stewardship (AMS) in care homes has compromised quality of evidence. A core outcome set (COS) is needed to facilitate interpretation and synthesis of evidence in this area.AIM: To determine outcomes deemed important by relevant stakeholders for interventions aimed at improving AMS in care homes, and to produce a refined list of outcomes that could be considered for use in future research.METHODS: Semi-structured face-to-face or telephone interviews were conducted with key stakeholders. Outcomes reported in previous randomised controlled trials (RCTs) of AMS in care homes were included in a topic guide for interviews. Content analysis was undertaken to identify potential outcomes suggested by participants, followed by further review.FINDINGS: Twenty-seven outcomes reported in RCTs were refined into a list of 12 overarching outcomes. Interviews with participants (six researchers, 31 healthcare professionals, and four family members of care home residents) identified 40 additional outcomes that were important to them. From these 52 outcomes, the total number of antimicrobials, the appropriateness of antimicrobial prescribing and adherence to guidelines were highlighted by most participants. After reviewing all 52 outcomes, a refined list of 14 outcomes potentially feasible for use in AMS trials in care homes was generated.CONCLUSION: A number of potential outcomes for AMS in care homes, some of which had not been reported in previous studies, were identified. The refined list of 14 outcomes will be used in a future study to agree a COS for care home AMS trials.

U2 - 10.1016/j.jhin.2019.12.024

DO - 10.1016/j.jhin.2019.12.024

M3 - Article

C2 - 31927037

JO - The Journal of hospital infection

JF - The Journal of hospital infection

SN - 0195-6701

ER -